Europe Rodent Control Market Forecast Analysis 2024-2032
According to Triton’s analysis, the Europe rodent control market is projected to rise at a CAGR of 7.39% in revenue over the forecast years 2024-2032.
The EU project PiedPiper introduced a groundbreaking pest control system to address the rise of anticoagulant-resistant super rats. In collaboration with Biotronics, project members are engaging with major pest control companies to leverage this innovative technology in the global market, valued at over €20 billion. This project also fosters increased collaboration between technology developers and major pest control companies in the European region. Additionally, it positions the region as a leader in tackling rodent resistance, creating opportunities for market expansion, and leading to sustainable rodent control solutions.
The countries explored in this region include the United Kingdom, Germany, France, Spain, Italy, Poland, and Rest of Europe.
Germany secures a major market share with revenue of approximately $145.96 million in 2023.
- The German rodent control market is expanding, influenced by prominent players like Rentokil and Anticimex. Rentokil leads with a diverse portfolio, including traps, baits, and cutting-edge digital pest control methods, while Anticimex emphasizes Integrated Pest Management (IPM) solutions.
- Similarly, digital pest control solutions, like smart traps and real-time monitoring, are transforming the industry with efficient, data-driven rodent management in the country.
- Notably, the German Environmental Agency (UBA), through the ‘NoCheRo’ Project, has initiated an e-consultation with Member States to assess urban rat control, particularly in sewage systems. The project aims to develop a certification scheme for non-chemical rodent control methods.
- The market is witnessing a growing demand for sustainable rodenticides and environmentally safe methods, driven by strict regulations and increasing consumer awareness of health and ecological impacts.
Rodent Control Market Forecast for the United Kingdom
A research study conducted by Direct Line Home Insurance reveals that local councils in the United Kingdom allocate an average of around $123,239 annually per council to tackle residential rodent infestations, amounting to a collective annual expenditure of approximately $43.91 million. This investment shows the growing challenge of rodent management amid awareness of rodent-borne diseases like leptospirosis and salmonellosis. The rising incidence of these diseases has heightened public and institutional recognition of the associated health risks, driving demand for effective rodent control solutions as a critical preventive measure. These factors lead to a promising growth of the rodent control market in the UK.
The rodent control market is segmented based on application and product. The product segment comprises biological, chemical, mechanical, and other product types. The biological type segment in the rodent control market categorizes products based on their active ingredients and mechanisms of action. It includes biologically derived solutions such as microbial or natural repellents. Biological rodent control options are gaining traction due to growing concerns about environmental sustainability and non-target species safety.
Contender Analysis in the Rodent Control Market:
BASF SE is a leading chemical company engaged in the production, marketing, and sales of a diverse range of products, including chemicals, plastics, crop protection solutions, and performance products. Its extensive portfolio includes solvents, adhesives, surfactants, fuel additives, fungicides, pigments, electronic chemicals, paints, food additives, and herbicides. BASF serves a broad spectrum of industries, such as construction, furniture and wood, agriculture, electronics and electrical, paints and coatings, automotive, home care, nutrition, and chemicals. The company is headquartered in Ludwigshafen/Rhein, Germany.
BASF Pest Control Solutions has expanded its rodenticide portfolio with the introduction of Neosorexa® Plus Blocks, which features flocoumafen as its active ingredient, offering a more potent formula.
Other contenders in the studied market are Neogen Corporation, Orkin LLC, Pelgar International, Ecolab Inc, Mccloud Services, and Rentokil Initial PLC.